Suppr超能文献

小鼠胎盘与胚胎之间发育过程中的全基因组DNA甲基化不对称性。

Developmental genome-wide DNA methylation asymmetry between mouse placenta and embryo.

作者信息

Legault L M, Doiron K, Lemieux A, Caron M, Chan D, Lopes F L, Bourque G, Sinnett D, McGraw S

机构信息

Research Center of the CHU Sainte-Justine , Montreal, Canada.

Department of Biochemistry and Molecular Medicine, Université De Montréal , Montreal, Canada.

出版信息

Epigenetics. 2020 Aug;15(8):800-815. doi: 10.1080/15592294.2020.1722922. Epub 2020 Feb 14.

Abstract

In early embryos, DNA methylation is remodelled to initiate the developmental program but for mostly unknown reasons, methylation marks are acquired unequally between embryonic and placental cells. To better understand this, we generated high-resolution DNA methylation maps of mouse mid-gestation (E10.5) embryo and placenta. We uncovered specific subtypes of differentially methylated regions (DMRs) that contribute directly to the developmental asymmetry existing between mid-gestation embryonic and placental DNA methylation patterns. We show that the asymmetry occurs rapidly during the acquisition of marks in the post-implanted conceptus (E3.5-E6.5), and that these patterns are long-lasting across subtypes of DMRs throughout prenatal development and in somatic tissues. We reveal that at the peri-implantation stages, the methyltransferase activity of DNMT3B is the main driver of methylation marks on asymmetric DMRs, and that DNMT3B can largely compensate for lack of DNMT3A in the epiblast and extraembryonic ectoderm, whereas DNMT3A can only partially compensate in the absence of DNMT3B. However, as development progresses and as DNMT3A becomes the principal methyltransferase, the compensatory DNA methylation mechanism of DNMT3B on DMRs becomes less effective.

摘要

在早期胚胎中,DNA甲基化会被重塑以启动发育程序,但由于大多原因不明,甲基化标记在胚胎细胞和胎盘细胞之间的获得是不平等的。为了更好地理解这一点,我们生成了小鼠妊娠中期(E10.5)胚胎和胎盘的高分辨率DNA甲基化图谱。我们发现了差异甲基化区域(DMRs)的特定亚型,这些亚型直接导致了妊娠中期胚胎和胎盘DNA甲基化模式之间存在的发育不对称。我们表明,这种不对称在植入后概念体(E3.5 - E6.5)的标记获取过程中迅速出现,并且这些模式在整个产前发育和体细胞组织中跨DMR亚型持续存在。我们揭示,在植入周围阶段,DNMT3B的甲基转移酶活性是不对称DMRs上甲基化标记的主要驱动因素,并且DNMT3B在很大程度上可以补偿上胚层和胚外外胚层中DNMT3A的缺失,而DNMT3A在没有DNMT3B的情况下只能部分补偿。然而,随着发育的进行以及DNMT3A成为主要的甲基转移酶,DNMT3B在DMRs上的补偿性DNA甲基化机制变得不那么有效。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验